Answers are grounded in this paper and cite their sources.
Septin-3 is a novel autoantibody target in patients with paraneoplastic cerebellar syndromes. Based on our findings, RC-IIFA with HEK293 cells expressing the septin-3/5/6/7/11 complex may serve as a screening tool to investigate anti-septin autoantibodies in serological samples with a characteristic staining pattern on neuronal tissue sections. Autoantibodies against individual septins can then be confirmed by RC-IIFA expressing single septins.
No takes yet. Share an insight, caveat, or question.
Miske et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: